Lecture 25 Inflammatory Bowel Disease Flashcards

1
Q

What is the definition of IBD

A

• Chronic, relapsing, remitting inflammation of gastrointestinal tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 2 main IBDs

A

Crohn’s and Ulcerative colitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What group is microscopic colitis found in and how is it diagnosed

A

Middle aged woman

Histology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of inheritance is IBD

A

Multi-factorial
Not-medelian
• Genetic susceptibility – SNPs (single nucleotide polymorphisms)- 1bp switch in genetic sequence- which may affect the function of the gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does increase permeability in the epithelium barrier lead to

A

Dysbosis and chronic inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Microbiota metabolic function

A

Production of vitamins
Digestion of dietary carcinogens
Fermentation of non-degradable substrates
Production of SCFAs- energy source

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Microbiota structural function

A

sIgA production
Intestinal villi and crypts
Mucous Layer
TJs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Microbiota protective function

A

Colonisation resistance
Innate and adaptive immunity
Inflammatory cytokine oversite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Extra-intestinal manifestation of IBD

A
  • Erythema nodusom
  • Ulcers on leg- PG (Crohn’s disease)
  • Arthritis in large joints
  • Sacroiliitis
  • Associated liver disease- sclerosing cholangitis
  • Gall stones and renal stones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Symptoms of Ulcerative colitis

A

o Bloody diarrhoea
o Abdominal pain
o Weight loss
o Fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Whats a distinctive feature of UC

A

only colon

• Begins rectum and works proximally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Investigations for UC

A
  • Bloods for markers of inflammation (normocytic anaemia, increased CRP/platelets, low albumin)
  • Stool culture to rule out infection
  • Faecal Calprotectin-non-invasive marker of inflammation in GI mucosa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mild UC

A

Less than 4 stools a day +/-blood
Normal ESR
No signs of toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Moderate UC

A

4-6 stools/day
Occasional blood
Minimal signs od toxicity
CRP<= 30mg/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Severe UC

A
More than 6 stills a day and:
Temp over 37.8
Tachycardia
Anaemia 
ESR>30mm/h
CRP>30mg/L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Filmiant UC

A
10 stools a day, continuous bleeding
Toxicity
Abdominal tenderness or distention
Transfusion requirement
Colonic dilatation (Xray)
17
Q

What is proctitis

A

UC confined to the rectum

18
Q

What are the features of proctitis

A
  • Frequency, urgency, incontinence- constant stimulation of pressure receptors, tenesmus
  • Small volume mucus and blood
  • Proximal faecal stasis (constipation)
19
Q

What is the treatment for proctitis

A

topical therapy via depository

20
Q

Interventions for acute severe colitis

A
  • Stool chart
  • 3-4 serial stool cultures for C. difficile- conditions increases susceptibility to infection
  • IV glucocorticoids- dampen down inflammation
  • LMWH- 3X increased risk of thromboembolism (anticoagulants)
  • Avoid/Stop non-steroidal analgesics, opiates, anti-diarrhoeals, anti-cholinergic
  • IV hydration, careful correction of electrolytes low potassium or magnesium can precipitate toxic megacolon
  • AXR – toxic dilatation, extent of disease – mucosal odema, lead pipe, proximal faecal loading
21
Q

Toxic megacolon

A

Dilated colon filled with air >5.5cm

22
Q

Clinical features of Crohn’s disease

A
•	Patchy disease  
–	mouth to anus 
–	skip lesions
–	clinical features 
depend on regions involved
23
Q

Clinical Features of CD

A
•	Diarrhoea
•	Abdominal pain
•	Weight loss. 
•	Malaise, lethargy, anorexia, N&amp;V, low-grade fever
•	Malabsorption
–	Anaemia, vitamin deficiency
24
Q

Investigations for CD

A
  • Bloods for markers of inflammation
  • Stool culture to rule out infection if diarrhoea
  • Faecal Calprotectin (0-50ug/g stool=normal, 50-200=equivocal, >200 elevated) – may not be high if just small bowel disease
  • Colonoscopy with terminal ileum intubation and colon/TI mucosal biopsies
  • MRI small bowel study
  • Capsule endoscopy- tablet with camera within it
  • Occasionally CT scan if acutely unwell and want to rule out complication eg abscess
25
Different in histology of UC and CD
``` – CD granulomas – Goblet cells depleted in UC – Crypt abscesses: UC > CD – Transmural inflammation in CD – Mucosal in UC ```
26
Symptoms of perianal Crohn's disease
Perianal pain Pus secretion Unable to sit down
27
Investigation of Perianal Crohn's disease
MRI pelvis | Examination under anaesthetic
28
Treatment for perianal Crohn's disease
Surgery to drain abscess | Medical – antibiotics and biologic therapy (anti-TNF)
29
Describe the step up approach for the treatment for UC
``` Aminosalicylates (5-ASA) Steroids-Prednisone/Budesonide Immunomodulators Biologic agents Surgery ```
30
Main Aminosalicylates (5-ASA)
Mesalazine • Work by blocking prostaglandins and leukotrienes • Topical to colonic mucosa can be taken orally
31
Can Aminosalicylates (5-ASA) work for Crohn's
No
32
What is Immunomodulation
– Thiopurines used for maintenance for UC and Crohn’s disease
33
Significant side effects of Immunomodulation
– Leucopenia (supress bone marrow function) more susceptible to infection – Hepatoxicity • Requires Blood Monitoring – Pancreatitis – Possible long-term lymphoma risk and non-melanoma skin cancers
34
Name biologics used
``` Monoclonal Antibodies • Anti-TNF antibodies – Infliximab (Remicade) • 8 weekly IV infusion – Adulimumab (Humira) • 2 weekly SC injections • 4b7 Integrin Blockers – Vedolizumab • 8 Weekly IV Infusions • IL12/IL23 Blockers – Ustekinumab • IV loading followed by SC 8-12 weekly ```
35
UC definition of failed medical therapy
* Recurrent courses of steroid (>2 courses a year) * Relapse prior to or shortly after stopping therapy * Unacceptable side effects * Acute severe colitis not responding to 72 hours high dose IV steroids +/- anti-TNF biologic ‘rescue’ therapy
36
Surgery for acute sever colitis
``` • Total colectomy o Create a rectal stump o Bring out end of small intestine in iliac fossa (end ileostomy) • Rectal preservation • Ileostomy ```
37
Surgical indicators for Crohn's disease
* Failure of medical management * Relief of obstructive symptoms (small bowel)- if there is development of a stricture * Management of fistulae - e.g. bowel to bladder * Management of intra-abdominal abscess * Management anal conditions * Failure to thrive